Latest Breaking News On - Lauren barbiero - Page 1 : comparemela.com

Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments

Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesLauren barbieroJoyce allaireAlex grayJoshua boyceRonald martellAlbertl shefferClinical immunological societyEuropean academy of allergyCompany phaseJasper therapeutics incTherapeutics reports first quarterRecent corporateChief executive officerFirst quarterAllergic diseases

Jasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones

- EU Clinical Trials authorized for Phase 1b/2a SPOTLIGHT and BEACON studies of briquilimab in CIndU and CSU, respectively

United statesJoyce allairePatricia carlosLauren barbieroEdwinj tuckerScott brunAlex grayRonald martellEuropean union orphan drug designationRegulatory affairs qualityEuropean medicines agencyAmerica society of hematologyCompany clinical trial applicationsJasper therapeutics incClinical trial applicationsChief executive officer

Jasper Therapeutics Highlights Recent Accomplishments and

- EU Clinical Trials authorized for Phase 1b/2a SPOTLIGHT and BEACON studies of briquilimab in CIndU and CSU, respectively - Patient enrollment in Phase.

United statesRonald martellAlex grayPatricia carlosJoyce allaireLauren barbieroScott brunEdwinj tuckerCompany clinical trial applicationsRegulatory affairs qualityJasper therapeutics incAmerica society of hematologyEuropean union orphan drug designationEuropean medicines agencyClinical trial applicationsChief executive officer

Jasper Therapeutics, Inc Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Dec. 18, 2023 Jasper Therapeutics, Inc. , a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit in mast cell-driven.

United statesAlex grayLauren barbieroJohn mullalyJasper therapeutics incEach optionJasper therapeuticsEquity incentive planNasdaq listing ruleAnnual reportQuarterly reports

Jasper Therapeutics, Inc Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jasper Therapeutics, Inc Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesLauren barbieroJohn mullalyAlex grayJasper therapeutics incEach optionJasper therapeuticsEquity incentive planNasdaq listing ruleAnnual reportQuarterly reports